MARKETS
Analyst Actions

Rodman & Renshaw Initiates Coverage On Agenus with Buy Rating, Announces Price Target of $19

Sep 28, 2026 · 07:58 AM ET· updated 13h ago

Rodman & Renshaw analyst Michael King initiates coverage on Agenus (NASDAQ:AGEN) with a Buy rating and announces Price Target of $19.

Share
Why It Matters

A stock expert thinks Agenus is worth buying at $19. When an expert starts watching a stock, it shows they see something interesting happening there.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.